Hypoparathyroidism epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The | *The prevalence of hypoparathyroidism is approximately 37 per 100,000 individuals worldwide.<ref name="pmid5393595">{{cite journal| author=Aliverdiev AA, Gireev GI, Gireeva TM| title=[Measures for preventing enzootic ataxia of lambs and buffalo calves]. | journal=Veterinariia | year= 1969 | volume= 46 | issue= 1 | pages= 71-2 | pmid=5393595 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5393595 }} </ref> | ||
===Prevalence=== | ===Prevalence=== | ||
Revision as of 12:32, 16 August 2017
|
Hypoparathyroidism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoparathyroidism epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hypoparathyroidism epidemiology and demographics |
|
Hypoparathyroidism epidemiology and demographics in the news |
|
Risk calculators and risk factors for Hypoparathyroidism epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
Epidemiology and Demographics
Incidence
- The prevalence of hypoparathyroidism is approximately 37 per 100,000 individuals worldwide.[1]
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
- The case-fatality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Aliverdiev AA, Gireev GI, Gireeva TM (1969). "[Measures for preventing enzootic ataxia of lambs and buffalo calves]". Veterinariia. 46 (1): 71–2. PMID 5393595.